Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesIgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura
Journal of Thrombosis and Haemostasis, 09/28/09
Ferrari S et al. – All IgG subclasses of anti–ADAMTS13 antibodies were detected in patients with acquired TTP, with IgG4, followed by IgG1, antibodies dominating the anti–ADAMTS13 immune response. Levels of IgG4 could be useful for the identification of patients at risk of disease recurrence.
Related Articles
Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura
International Journal of Hematology, 10/12/09
Relevance Score: 97%
Priapism and Penile Gangrene Due to Thrombotic Thrombocytopenic Purpura
Urology, 11/09/09
Relevance Score: 96%
Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura
Blood, 10/02/09
Relevance Score: 96%
Clinical-Pathological Features and Prognosis of Thrombotic Thrombocytopenic Purpura in Patients With Lupus Nephritis
The American Journal of the Medical Sciences, 11/13/09
Relevance Score: 95%
Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus
Modern Rheumatology, 10/22/09
Relevance Score: 95%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Overview of hypersensitivity to cancer therapies
Community Oncology , 03/19/10
Radioimmunotherapy: a promising treatment strategy for follicular lymphoma
Community Oncology , 03/19/10
CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells
Immunology & Cell Biology, 03/19/10
Article Search
Sponsor
Sponsor